WWA
GILD icon

Wingate Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Wingate Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,276
Closed -$118K – 217
2024
Q4 		$118K Buy
+1,276
New +$115K 0.12% 129

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Wingate Wealth Advisors's GILD Position: Q1 2025 in Review

Wingate Wealth Advisors sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 1,276 shares — an estimated $118K sold.

Wingate Wealth Advisors first reported a position in GILD in Q4 2024 and held it in 1 quarter. The position peaked at $118K in Q4 2024. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • Wingate Wealth Advisors reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
  • Wingate Wealth Advisors sold 1,276 Gilead Sciences shares in Q1 2025, an estimated $118K.
  • Wingate Wealth Advisors first reported a position in Gilead Sciences in Q4 2024 and held it in 1 quarter.
  • Wingate Wealth Advisors's Gilead Sciences position peaked at $118K in Q4 2024.
  • 2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Wingate Wealth Advisors's 13F filing for Q1 2025, filed 24 Apr 2025.